TriSalus Life Sciences TLSI Cash Flow Statement (2020-2026)

NASDAQ TLSI
$3.67 +0.01 (+0.27%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

TriSalus Life Sciences Quarterly Cash Flow Statement

Periods 23 quarters
Latest Jun 2026

TriSalus Life Sciences reported cash from operations of -$10.13M and free cash flow of -$10.21M for the quarter ended Jun 2026, down 38.4% year over year. This cash flow statement covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
1.86M2.90M-7.87M-8.68M-8.09M-22.54M-8.31M-13.99M-1.43M-35.64M-13.21M-4.33M-2.40M-10.11M-10.38M-8.29M-10.81M-9.75M1.54M-9.19M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.27M0.17M0.18M0.24M0.26M0.28M0.28M0.30M0.34M
Depreciation & Amortization (CF)Dep. & Amort.
-0.05M0.18M0.15M0.16M0.19M0.18M0.19M0.18M0.19M0.17M0.17M0.16M0.13M0.14M0.14M
Share-based CompensationStock Comp.
0.12M0.07M0.07M0.26M1.00M1.09M1.28M1.38M1.70M1.62M1.89M3.42M2.20M2.47M2.62M
Gains from Sales and DivestituresGains Divest
-0.26M-0.02M-0.04M0.02M-0.02M-0.01M-0.12M0.00M0.00M
Gains from Investment SecuritiesGains Investment
-2.21M2.42M1.07M0.02M-12.38M2.52M-9.44M-0.59M-0.84M-0.33M-2.93M0.01M3.90M2.57M
Other non-cash itemsOther Non-Cash
-2.65M-4.03M-3.45M-2.39M8.31M1.48M4.23M-19.90M9.87M4.06M-13.69M-2.36M1.09M1.26M-0.70M-2.52M5.04M-7.37M1.00M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.74M0.04M0.50M0.94M0.50M0.72M0.43M0.21M0.36M0.37M0.17M-0.50M1.59M-1.29M1.27M
Change in InventoryChange Inventory
0.19M0.25M-0.20M0.11M0.92M0.37M0.53M0.56M0.05M0.11M-0.36M-0.53M-0.20M0.70M0.43M
Change in Accured ExpensesChange Accured Exp.
0.34M0.36M0.21M-0.51M1.40M4.14M0.02M2.04M-4.63M5.41M-0.31M-2.36M-2.03M0.30M1.62M-1.81M1.51M0.69M0.16M-0.59M
Change in TaxesChange Taxes
0.14M-0.14M0.03M-0.02M
Change in Other Operating AssetsOther Assets Change
-0.10M-0.10M-0.03M-0.10M1.43M1.40M0.35M-0.08M-1.31M0.01M-1.00M2.98M0.30M-0.62M-0.51M-0.27M0.13M-0.20M0.42M0.20M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.13M-0.07M0.13M-0.26M-0.08M-0.09M-0.09M-0.07M-0.04M-0.06M-0.03M-0.03M-0.03M-0.03M-0.03M
Other Working Capital ChangesOther WC Changes
0.10M0.10M0.03M0.10M-1.43M-1.52M-0.42M0.21M1.05M-0.09M0.91M-3.07M-0.37M0.58M0.46M0.24M-0.16M0.17M-0.45M-0.23M
Cash from OperationsCash from Ops.
-0.37M-0.68M-0.43M-0.70M-22.88M-8.31M-10.50M-9.24M-21.66M-9.18M-10.87M-13.42M-10.85M-5.71M-4.50M-7.32M-3.71M-2.48M-6.48M-10.13M
Investing Activities
Capital ExpendituresCapex
0.20M0.01M0.03M0.18M0.37M0.07M0.06M0.17M0.05M0.75M-0.09M0.22M0.04M0.14M0.08M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.04M0.04M
Change in Property, Plant and EquipmentChange in PP&E
-0.20M-0.01M-0.03M-0.18M-0.37M-0.07M-0.06M-0.17M-0.05M-0.71M0.09M-0.18M-0.04M-0.14M-0.08M
Change in IntangiblesChange Intangibless
0.07M0.07M0.00M0.14M0.33M
Purchase of InvestmentsInvestments Purchased
0.23M0.19M
Cash from Investing ActivitiesCash from Investing
0.01M0.08M-1.61M-0.27M-0.07M-0.03M-1.11M-0.37M-0.07M-0.06M-0.17M-0.05M-0.71M0.09M-0.18M-0.04M-0.14M-0.08M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.27M0.14M0.04M0.53M-0.53M25.00M10.00M
Long-Term Debt RepaymentsLT Debt Repayment
0.13M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.07M0.00M0.01M0.00M0.01M0.02M
Non-Current Debt
0.27M0.14M-0.09M0.51M-0.55M-0.02M-0.02M-0.02M24.98M-0.02M-0.02M9.93M0.00M-0.01M0.00M-0.01M-0.02M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.27M0.14M-0.09M0.51M-0.55M-0.02M-0.02M-0.02M24.98M-0.02M-0.02M9.93M0.00M-0.01M0.00M-0.01M-0.02M
Change in Capital Stock
Common Stock IssuedStock Issued
0.02M4.77M4.83M36.98M0.09M3.15M3.61M5.85M3.01M0.28M20.72M1.64M0.28M42.66M0.29M
Net Shares Issued and RepurchasedNet Shares Issued
0.02M4.77M4.83M36.98M0.09M3.15M3.61M5.85M3.01M0.28M20.72M1.64M0.28M42.66M0.29M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
10.00M3.18M6.00M0.01M
Net Equity Issued and RepurchasedNet Equity Issued
10.02M7.95M10.83M36.98M0.09M3.15M3.61M5.85M3.01M0.28M20.72M1.64M0.28M42.66M0.29M
Other financing activitiesOther financing
0.20M-0.20M-1.12M-0.02M-2.59M-0.01M-0.52M-1.55M1.57M-0.26M-0.32M
Cash from Financing ActivitiesCash from Financing
0.27M0.64M6.65M5.91M7.93M6.40M40.25M0.04M3.13M25.99M5.82M2.99M9.69M20.72M0.08M0.28M42.39M-0.05M
Additional items
Change in Cash
-0.37M-0.08M-0.15M0.02M-17.83M-2.67M-2.65M-2.86M17.48M-9.51M-7.81M12.51M-5.19M-2.76M4.48M13.49M-3.80M-2.25M35.76M-10.27M
Ending Cash Balance
0.28M30.30M0.05M0.07M12.34M9.66M7.02M4.15M21.63M12.13M4.32M16.83M11.64M8.88M13.35M26.84M23.04M20.79M56.55M46.29M
Free Cash FlowFCF
-0.37M-0.68M-0.43M-0.70M-22.88M-8.51M-10.51M-9.27M-21.84M-9.55M-10.93M-13.48M-11.02M-5.76M-5.25M-7.23M-3.93M-2.53M-6.62M-10.21M
Net Cash FlowNCF
-0.37M-0.68M-0.15M0.02M-17.83M-2.67M-2.65M-2.86M17.48M-9.51M-7.81M12.51M-5.19M-2.76M4.48M13.49M-3.80M-2.25M35.76M-10.27M
Interest Paid
0.00M0.45M1.31M-0.01M0.71M0.85M0.97M1.17M1.14M1.15M
Income Taxes PaidTaxes Paid
-0.05M0.00M0.01M0.00M0.02M

TriSalus Life Sciences Cash Flow Statement API

Pull TriSalus Life Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TLSI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY